— Know what they know.
Not Investment Advice
Also trades as: 2126.HK (HKSE) · $vol 0M

JWCTF Earnings

JW (Cayman) Therapeutics Co. Ltd
1W: +0.0% 1M: +0.0% 3M: -14.8% YTD: -43.8% 1Y: -58.9% 3Y: -56.6%
$0.20
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · $84.2M mcap · 319M float · 0.0007% daily turnover · Short 100% of daily vol
Last Earnings 2026-08-27
EPS
¥-0.02 (US$-0.00)
▼ Miss +0.0%
Revenue
¥16M ($2M)
▲ Beat +0.0%

Estimate vs Actual

Earnings Surprise History

2/13
EPS Beats
1/13
Revenue Beats
15%
EPS Beat Rate
8%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥325,791,181 ¥325,310,631
2026-10-02 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥844,688,620 ¥843,442,683
2026-10-01 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥325,419,847 ¥325,791,181
2026-10-01 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥843,725,851 ¥844,688,620
2026-09-30 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥325,070,356 ¥325,419,847
2026-09-30 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥842,819,715 ¥843,725,851
2026-09-29 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥325,332,474 ¥325,070,356
2026-09-29 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥843,499,317 ¥842,819,715
2026-09-28 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥325,157,729 ¥325,332,474
2026-09-28 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥843,046,249 ¥843,499,317
2026-09-25 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥325,944,084 ¥325,157,729
2026-09-25 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥845,085,055 ¥843,046,249
2026-09-24 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥326,162,515 ¥325,944,084
2026-09-24 annual 2027-12-31 ¥-0.51 ¥-0.51 — ¥845,651,390 ¥845,085,055
2026-09-23 annual 2026-12-31 ¥-0.80 ¥-0.80 — ¥326,053,299 ¥326,162,515
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms